ArticlePDF Available

Sudden Onset of Oromandibular Dystonia after Cerebellar Stroke

Authors:
Case Reports
Sudden Onset of Oromandibular Dystonia after Cerebellar Stroke
Alper Akin, Rezzak Yilmaz*, Ferda Selcuk & M. Cenk Akbostancı
Department of Neurology, School of Medicine, Ankara University, Ankara, Turkey
Abstract
Background: We present the case of a 65-year-old female with sudden-onset involuntary mouth opening, deviation of the jaw, facial grimacing, and tongue
movements that started 6 months prior to her admission.
Case Report: She was diagnosed with oromandibular dystonia. Differential diagnosis of oromandibular dystonia and various etiologies were investigated.
Neuroimaging studies revealed a left cerebellar infarction.
Discussion: To our knowledge, this case is the first oromandibular dystonia presenting with cerebellar ischemic stroke. Possible roles of the cerebellum for the
pathophysiology of oromandibular dystonia are discussed.
Keywords: Dystonia, oromandibular dystonia, cerebrovascular disease
Citation: Akin A, Yilmaz R, Selcuk F, et al. Sudden onset of oromandibular dystonia after cerebellar stroke. Tremor Other Hyperkinet Mov. 2014; 4. doi: 10.
7916/D8C24TN3
* To whom correspondence should be addressed. E-mail: rezzakyilmaz@yahoo.com
Editor: Elan D. Louis, Columbia University, USA
Received: June 26, 2014 Accepted: August 19, 2014 Published: October 28, 2014
Copyright: 2014 Akin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution–Noncommercial–No Derivatives License, which permits
the user to copy, distribute, and transmit the work provided that the original author(s) and source are credited; that no commercial use is made of the work; and that the work is not altered
or transformed.
Funding: None.
Financial Disclosures: C.A.: Consultancies: Bohringer Ingelheim, Lundbeck, Abbvie, Medtronic; Honoraria: Abbott, Abdi Ibrahim, Allergan, Bohringer Ingelheim, Gen Ilac¸,
Generica, Glaxo Smith Kline, Medtronic, Lundbeck, Novartis, Ilko, Santa Farma.
Conflict of Interest: The authors report no conflict of interest.
Introduction
Oromandibular dystonia (OMD) is a cranial segmental dystonia of
the lips, jaw, and tongue, causing involuntary mouth closure or
opening, deviation of the jaw, tongue movements, or any combination
of these due to repetitive or sustained spasms of masticatory, facial, or
lingual muscles. OMD is the most frequent cranial dystonia after
blepharospasm
1
and can occur in isolation or appear together with
other forms of craniocervical dystonia.
2
Although drug-induced, post-
anoxic, neurodegenerative disorder-associated, and head injury-
associated etiologies have been reported, the cause of OMD is
unknown in the majority of patients. Other types of dystonia associated
with cerebellar disease are known,
3–5
but reports of OMD related to
cerebellar stroke are rare.
6
We present a case of OMD following a
cerebellar ischemic stroke.
Case Report
A 65-year-old female was admitted because of involuntary mouth
and tongue movements. She reported a sudden onset of gait problems
accompanying these abnormal movements beginning 6 months prior
to her referral. Her medical history revealed hypertension and diabetes
mellitus. Her medication history was unremarkable for dystonia. She
had no history of consanguineous marriage and she had seven first-
degree relatives who had never experienced any neurological disease.
On neurological examination she exhibited deviation of the jaw to the
left, right, or front, or a combination of these, together with lingual and
perioral dystonia (Video 1). These movements were more pronounced
during speech and chewing. The dystonic movements diminished with
oral sensory feedback, such as holding a toothpick in her mouth. Her
left upper and lower extremities were dysmetric and dysdiadochoki-
netic. She had slightly hyperactive deep tendon reflexes on the left side
and her gait was ataxic. Her psychiatric examination was normal. Her
complete blood count and biochemical tests were normal, except for
high blood sugar levels (250 mg/dL) and hyperlipidemia (low-density
lipoprotein: 176 mg/dL). Tests for ferritin, folate, and vitamin B12
levels were normal. She had high blood pressure (175/90 mm/Hg).
Magnetic resonance imaging (MRI) showed chronic anterior inferior
cerebellar artery infarction (Figure 1). Wilson’s disease was excluded
as the Kayser–Fleischer ring was not seen on ophthalmologic
Freely available online
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services
1
examination and the ceruplasmin value was normal (24.3 mg/dL). Her
peripheral blood smear was normal. She was treated with electro-
myographically guided botulinum toxin-A injections (BotoxH), with 10
units to both masseter muscles, 5 to both digastric muscles, 15 to both
lateral pterygoidei muscles, and 5 units to the platysma muscles, which
provided moderate benefit.
Discussion
For decades, dystonia was thought to be a disorder of the basal
ganglia.
7
However, along with the basal ganglia, the cerebellum has
been shown to contribute to the pathophysiology of dystonia.
8
This
contribution has been demonstrated in several imaging and molecular
studies, most of which were focused on primary dystonia, shedding
light on the mechanism of the dystonic phenomenon.
The problem underlying the dystonic phenomenon is now under-
stood at the circuit level, namely the cerebello-thalamo-cortical
network.
9
In macaques, the link between the dentate nucleus and
the striatum was shown by histological tract tracing.
10
Another study
showed a return pathway from the basal ganglia to the cerebellum.
11
Aberrant cerebellar activities in dystonic animals and decrease in
dystonia with the removal of the cerebellum in rats have been
reported.
12
In humans, the modulation of cortical excitability by cerebellar
outputs via the basal ganglia-thalamo-cortical network has been
shown.
13
The GABAergic inhibition in the primary motor cortex by
the cerebello-thalamo-cortical network may be deficient in dystonia. It
has been proposed that cerebellar outputs alter basal ganglia activity,
leading to dystonic movements.
14
Moreover, changes of striatal
dopamine levels with cerebellar stimulation
8
and loss of cerebellar
Purkinje cells in adult-onset primary focal dystonia have been shown.
15
Furthermore, reduction in the connection between the cerebellum and
the thalamus and microstructural abnormalities in the vicinity of the
superior cerebellar peduncle have been reported in DYT mutation
carriers.
16
All of these reports favor the connection of the cerebello-
thalamo-cortical and basal ganglia-thalamo-cortical networks in both
animals and humans.
The cerebellum is thought to be responsible for processing
proprioceptive information and changing the somatosensory thresh-
olds in the cortex.
17
In this sense, dystonia may be the result of the
abnormal inhibition and plasticity of sensorimotor pathways.
8
Indeed,
lack of inhibition, sensory dysfunction, and abnormal plasticity may all
be major causes of the dystonic phenomena.
18
Detection of increased
metabolism in the cerebellum and dorsal midbrain using fluorodeox-
yglucose positron emission tomography in dopa-responsive dystonia
supports this notion.
19
A study with voxel-based morphometry also
found increased gray matter volume in the cortex, basal ganglia, and
cerebellum in idiopathic cervical dystonia.
20
Studies showing the relationship between cerebellar disease and
OMD have been reported.
3,4
Although the cause is not known in the
majority of cases, there are some cases induced by drugs, anoxia,
cerebellopontine angle meningioma, or cerebrotendinous xanthoma-
tosis.
21,22
On the other hand, OMD related to a cerebellar stroke has
only been reported once: a case of late-onset OMD following a
cerebellar hemorrhage.
6
Such late-onset dystonia following an event
has been attributed to maladaptive plasticity. Waln and LeDoux
6
noted the slow development of reorganization leading to super-
sensitivity and abnormal rewiring within the cerebellar nuclei. These
reports are in accordance with the concept about abnormal plasticity.
Figure 1. T1 and T2 Images. The images show chronic anterior inferior cerebellar artery infarction.
Video 1. Patient with Oromandibular Dystonia. The video shows
repetitive contractions of jaw, tongue, and perioral muscles in our patient.
Akin A, Yilmaz R, Selcuk C, et al. Oromandibular Dystonia
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services
2
We herein report a case of OMD due to ischemia of the cerebellum.
To our knowledge, this case is the first report of OMD following a
cerebellar ischemic stroke. We argue that acute ischemia might have
caused disruption of the output from Purkinje cells, resulting in the loss
of GABAergic inhibition of the motor cortex via the cerebello-
thalamo-cortical network.
By the time our patient was admitted, it was already 6 months since
the beginning of the dystonic movements. She asserted that her
dystonia and ataxia started simultaneously. As we had not followed the
patient from the beginning, the possibility of other etiologies also
needed to be discussed; in our clinical and laboratory work-up, we
could find no evidence in favor of neurodegeneration. A review of the
prescription, her family history, and other neuropsychiatric features,
together with MRI and blood tests, enabled us to exclude drug-
induced, heredodegenerative dystonia and dystonia-plus syndromes.
The main shortcoming was that we could not perform a genetic
analysis in this case. However, we thought that a diagnosis of primary
dystonia was unlikely in our patient, considering her overall radiologic
and clinical picture. She had a sudden-onset focal dystonia without a
tendency for generalization. Her age was even higher than that for
late-onset primary dystonia-like DYT 7 or 13.
23
Moreover, apparent
evidence for brain injury and additional cerebellar symptoms strongly
suggested secondary dystonia as a diagnosis for our case.
A remarkably unusual point in our case is the instant onset of
dystonia following the stroke. It raises a possibility that the lesion and
the dystonia may be unrelated. In that case, our patient would fall into
a category of late-onset primary focal dystonia, which we believe
unlikely for the reasons we have discussed above (particularly with
sudden and simultaneous onset with other cerebellar stroke signs).
Generally, one would expect dystonia to appear later on, due to the
process of maladaptive plasticity, ranging from months to years.
24
However, although rare, it may appear in a much shorter time, such as
in days.
25,26
Moreover, Scott and Jankovic
24
reported that the older
the patient, the shorter the latent period between the cause and the
dystonia.
Nevertheless, we were cautious about believing our patient’s
assertion, since it had been 6 months from the beginning of the
symptoms. If we assumed a latent period for dystonia in our patient, it
still had to be a very short period. We lost contact with the patient after
her discharge, so we are unable to confirm this statement or re-
examine her. We believe that lack of latency for dystonia in our patient
indicates that slow processes such as maladaptive plasticity or
reorganization are unlikely as causes of OMD.
Cerebellar diseases related with dystonia vary broadly in etiology
but less in the clinical outcome. Rumbach et al.
3
reported a case with
hemidystonia due to infarction of the posterior and superior cerebellar
arteries. This case had a similar but larger infarct than our case. One
might argue that our case could have a more generalized dystonia, if
she had had a larger lesion. Also, Alarco´n et al.
4
reported a central
mass of the cerebellum with upper limb dystonia. In our patient,
however, the lesion was more lateral. Our patient’s dystonia was in the
mouth and tongue, which were anatomically in accordance with the
cerebellar homonculus.
27
The cellular pathophysiology of ataxia and dystonia seems to be
different. Lehe´ricy et al.
28
proposed that dystonia may be caused by
dysfunction of the cerebellum, whereas ataxia is the result of
destruction. Furthermore, as the cerebellum has structurally different
functional areas, one region may be affected more severely than the
other by means of ‘‘selective vulnerability,’’ resulting in the destruction
of one area and distortion of the other area, yielding different clinical
pictures.
15
In our patient, the ischemia was partial; she had an ataxia
along with a focal dystonia, but we are unable to comment on whether
she would still have dystonia if she had a different lesion. Destruction
in the cerebellar tissue as the cause of ataxia is more pronounced than
dystonia in patients with ischemia. As studies about the cerebello-
thalamo-cortical network accumulate and more cases with cerebellar
stroke and OMD are reported, the exact role of the cerebellum in
OMD and other focal dystonia may be elucidated.
References
1. Nutt JG, Muenter MD, Melton LJ, Aronson A, Kurland LT.
Epidemiology of dystonia in Rochester, Minnesota. Adv Neuro 1988;50:361–365.
2. Colosimo C, Suppa A, Fabbrini G, Bologna M, Berardelli A.
Craniocervical dystonia: Clinical and pathophysiological features. Eur J Neurol
2010;17(Suppl 1):15–21.
3. Rumbach L, Barth P, Costaz A, Mas J. Hemidystonia consequent upon
ipsilateral vertebral artery occlusion and cerebellar infarction. Mov Disord 1995;
10:522–525.
4. Alarco´n F, Tolosa E, Mun˜oz E. Focal limb dystonia in a patient with a
cerebellar mass. Arch Neurol 2001;58:1125–1127.
5. Tranchant C, Maquet J, Eber AM, Dietemann JL, Franck P, Warter JM.
Cerebellar cavernous angioma, cervical dystonia and crossed cortical diaschisis.
Rev Neurol 1991;147:599–602.
6. Waln O, LeDoux MS. Delayed-onset oromandibular dystonia after a
cerebellar hemorrhagic stroke. Parkinsonism Relat Disord 2010;16:623–625.
7. Marsden CD, Quinn NP. The dystonias. BMJ 1990;300:139–144.
8. Neychev VK, Fan X, Mitev VI, Hess EJ, Jinnah HA. The basal ganglia
and cerebellum interact in the expression of dystonic movement. Brain 2008;
131:2499–2509.
9. Niethammer M, Carbon M, Argyelan M, Eidelberg D. Hereditary
dystonia as a neurodevelopmental circuit disorder: Evidence from neuroima-
ging. Neurobiol Dis 2011;42:202–209.
10. Hoshi E, Tremblay L, Feger J, Carras PL, Strick PL. The cerebellum
communicates with the basal ganglia. Nat Neurosci 2005;8:1491–1493.
11. Bostan AC, Strick PL. The cerebellum and basal ganglia are
interconnected. Neuropsychol Rev 2010;20:261–270.
12. LeDoux MS, Lorden JF, Ervin JM. Cerebellectomy eliminates the motor
syndrome of the genetically dystonic rat. Exp Neurol 1993;120:302–310.
13. Daskalakis ZJ, Paradiso GO, Christensen BK, et al. Exploring the
connectivity between the cerebellum and motor cortex in humans. J Physiol
2004;557:689–700.
14. Neychev VK, Gross RE, Lehe´ricy S, et al. The functional neuroanatomy
of dystonia. Neurobiol Dis 2011;42:185–201.
Oromandibular Dystonia Akin A, Yilmaz R, Selcuk C, et al.
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services
3
15. Prudente CN, Pardo CA, Xiao J, et al. Neuropathology of cervical
dystonia. Exp Neurol 2013;241:95–104.
16. Carbon M, Kingsley PB, Su S, et al. Microstructural white matter
changes in carriers of the DYT1 gene mutation. Ann Neurol 2004;56:283–286.
17. Restuccia D, Valeriani M, Barba C, et al. Functional changes of the
primary somatosensory cortex in patients with unilateral cerebellar lesions. Brain
2001;124:757–768.
18. Quartarone A, Hallett M. Emerging concepts in the physiological basis
of dystonia. Mov Disord 2013;28:958–67.
19. Asanuma K, Carbon-Correll M, Eidelberg D. Neuroimaging in human
dystonia. J Med Invest 2005;52:272–279.
20. Draganski B, Thun-Hohenstein C, Bogdahn U, et al. ‘‘Motor circuit’’
gray matter changes in idiopathic cervical dystonia. Neurology 2003;61:1228–
1231.
21. Alcalay R, Wu S, Patel S, et al. Oromandibular dystonia as a
complication of cerebrotendinous xanthomatosis. Mov Disord 2009;24:1397–
1399.
22. Persing JA, Muir A, Becker DG, et al. Blepharospasm-oromandibular
dystonia associated with a left cerebellopontine angle meningioma. J Emerg Med
1990;8:571–574.
23. Schmidt A, Klein C. The role of genes in causing dystonia. Eur J Neurol
2010;17(Suppl 1):65–70.
24. Scott BL, Jankovic J. Delayed-onset progressive movement disorders
after static brain lesions. Neurology 1996;46:68–74.
25. Krauss JK, Mohadjer M, Braus DF, Mundinger F. Dystonia following
head trauma: A report of nine patients and review of the literature. Mov Disord
1992;7:263–272.
26. O’Rourke K, O’Riordan S, Gallagher J, Hutchinson M. Paroxysmal
torticollis and blepharospasm following bilateral cerebellar infarction. J Neurol
2006;253:1644–1645.
27. Manni E, Petrosini L. A century of cerebellar somatotopy: A debated
representation. Nat Rev Neurosci 2004;5:241–249.
28. Lehe´ricy S, Tijssen MA, Vidailhet M, et al. The anatomical basis of
dystonia: Current view using neuroimaging. Mov Disord 2013;28:944–957.
Akin A, Yilmaz R, Selcuk C, et al. Oromandibular Dystonia
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services
4
... The introduction of rTMS targeting the cerebellum provided initial short-term improvement, aligning with the role of the cerebellum in motor control and dystonia pathophysiology. [5] Hereditary dystonia's involvement of the cerebellum, as shown by increased glucose metabolic activity, abnormal Purkinje cell activity and impaired cerebella-thalami-cortical tracts, [6,7] supported our initial choice to target the cerebellum. The initial positive response aligns with this. ...
Article
We injected 25 U into each masseter muscle and 10 unit into orbicularis oris over four points.), along with tablet tetrabenazine 25 mg per day and tablet Clonazepam 1 mg per day in divided dosages, provided temporary relief. He remained symptomatic while on the same medications, with severe facial muscle contractions affecting his ability to speak, eat, and drink. The patient was later referred to the psychiatry department for neuromodulation. At the time of assessment, he was also reporting persistent, pervasive low mood, low confidence, reduced interest in any pleasurable activity, loss of appetite, and hopelessness for the past 2 months. Repetitive Transcranial Magnetic Stimulation (rTMS) with TBS was planned for oromandibular dystonia, alongside tablet Sertraline 50 mg daily (for depression) and Baclofen 20 mg per day. His involuntary movements were assessed using a standardized scale that includes the Abnormal Involuntary Movement Scale (AIMS), which has been used extensively in the assessment of dystonia in the previous studies. [2] This assessment was conducted at baseline and after every 10 sessions of TBS. The resting motor threshold (RMT) was adjusted after every 10 sessions, and target areas were identified using the 10-20 EEG system. Initially, he underwent 20 sessions (2 sessions/day) targeting the bilateral cerebellum [3] (3 cm lateral to inion on both sides sequentially), which resulted in initial significant improvement in symptoms followed by again worsening of the symptoms. However, extending the sessions to 40 did not provide additional benefits. The patient was lost to follow-up and returned after 4 months. At that time, he was taking Tetrabenazine 25 mg twice daily, tablet Baclofen 10 mg twice a day and Clonazepam 1 mg per day, but with minimal relief and persistence of his depressive symptoms. The patient was additionally started on Bupropion 150 mg per day for co-morbid depression without the cover of mood stabilizers as he did not have any past or family history of manic or hypomanic episodes. He was given 12 sessions of transcranial direct current stimulation with anode over left dorsolateral prefrontal cortex and cathode over inion (Iz) at current intensity of 3 mA for 30 min/session over 12 days. It resulted in noticeable improvement in his depressive symptoms but, minimal improvement in dystonia. He was on same treatment for next 2 months with persistence of dystonia, after which neuromodulation was again planned for Oro-mandibular dystonia at different site. Dear Editor, Oromandibular dystonia is a rare movement disorder characterized by involuntary, intermittent, or sustained repetitive muscle contractions of the face and jaw. [1] This often leads to difficulties in speaking, eating, and facial expression. Maladaptive plasticity involving the striatum, thalamus, cerebellum, and their functional connectivity results in abnormalities in sensorimotor integration and neural inhibitory control and may play a role in the pathogenesis of dystonia. [1] This case report discusses a 42-year-old male who presented with a progressive 5-year history of orofacial dystonia with co-morbid bipolar disorder. Despite multiple pharmacological interventions, including trihexyphenidyl, clonazepam, tetrabenazine, and botulinum toxin injections, the patient's symptoms persisted, severely impacting his quality of life. In this case, neuromodulation through theta burst stimulation (TBS) was explored as a potential treatment option. The initial approach involved targeting the cerebellum, followed by stimulation of the supplementary motor area (SMA), which resulted in varying degrees of improvement. A 42-year-old male orator with no prior history of psychiatric or neurological conditions presented with a 5-year history of gradually worsening episodes of repetitive grimacing and involuntary closure of the mouth. Initially, he experienced slurring of speech for 1 year, which persisted despite taking tablet Trihexyphenidyl 4 mg per day and tablet Clonazepam 1 mg per day. Following this, he experienced jaw pain accompanied by involuntary lip movements, which progressively worsened over the following months, including patterned contractions of peri-oral muscles. As his condition deteriorated over the years, he became unable to speak clearly, consume solid food, and drink liquids with difficulty. In 2022, he sought treatment at the neurology unit of our center. Investigations, including MRI, ceruloplasmin, and serum copper levels, were normal. Whole genome sequencing revealed a Variant of Uncertain Significance (VUS) in the VPS13D gene, associated with autosomal recessive spinocerebellar ataxia. He initially received a 40 IU botulinum toxin injection, which improved his speech and facial movements, although the effects lasted only 3-4 weeks. A subsequent higher dose of 100 IU Botulinum (We injected Botulinum toxin A Ona botulinum [Botox], 100 U diluted in 2 ml normal saline.
Article
Full-text available
Background In this report, we describe rare two pediatric cases that developed oro-mandibular dystonia due to moyamoya disease. Case Description A 7-year-old boy presented with oro-mandibular dystonia and transient weakness of the left extremities, and was diagnosed as moyamoya disease. Another 7-year-old boy developed oro-mandibular dystonia alone and was diagnosed as moyamoya disease. In both, cerebral blood flow (CBF) was markedly decreased in the involved hemispheres, including the basal ganglia and cerebral cortex. They successfully underwent combined bypass surgery and experienced no further attacks of oromandibular dystonia during follow-up periods. CBF almost normalized through surgical collaterals through direct and indirect bypass. Conclusion When treating patients with oro-mandibular dystonia, moyamoya disease should be listed as one of the differential diseases. The underlying mechanism of oro-mandibular dystonia in moyamoya disease is still unclear, but persistent cerebral ischemia in the basal ganglia and/or parietal lobe may play a key role to induce this rare symptom.
Article
Introduction Oromandibular dystonia (OMD) is a diagnosis based on clinical signs and symptoms, presenting in varied forms and severities. Knowledge of clinical characteristics would help in early diagnosis and treatment of OMD. We aim to describe the prevalence and clinical characteristics of patients with OMD who presented to an academic Orofacial Pain clinic. Methods In this retrospective study, we identified OMD patients with ICD-9 (333.82) and ICD-10 (G24.4) diagnostic codes from October 2012 to December 2017. Additional selection criteria were age >18 years old and confirmation of OMD diagnosis with at least one follow-up visit. Results Over 5-year period, 22 patients with OMD were identified by ICD diagnostic codes, and of those, 6 patients met selection criteria corresponding to prevalence of 170 per 100,000 (95% CI 70, 390). The most common chief complaint was jaw pain (67%), and all patients had associated diagnosis of myofascial pain of masticatory muscles. Conclusion The prevalence of patients with OMD in an academic Orofacial Pain clinic is higher than previously reported population-based studies. The presentation of OMD often includes TMD with involvement of various masticatory muscles.
Article
Full-text available
Dystonia is a neurological disorder characterized by excessive involuntary muscle contractions that lead to twisting movements or abnormal posturing. Traditional views place responsibility for dystonia with dysfunction of basal ganglia circuits, yet recent evidence has pointed towards cerebellar circuits as well. In the current studies we used two strategies to explore the hypothesis that the expression of dystonic movements depends on influences from a motor network that includes both the basal ganglia and cerebellum. The first strategy was to evaluate the consequences of subthreshold lesions of the striatum in two different animal models where dystonic movements are thought to originate from abnormal cerebellar function. The second strategy employed microdialysis to search for changes in striatal dopamine release in these two animal models where the cerebellum has been already implicated. One of the animal models involved tottering mice, which exhibit paroxysmal dystonia due to an inherited defect affecting calcium channels. In keeping with prior results implicating the cerebellum in this model, surgical removal of the cerebellum eliminated their dystonic attacks. In contrast, subclinical lesions of the striatum with either 6-hydroxydopamine (6OHDA) or quinolinic acid (QA) exaggerated their dystonic attacks. Microdialysis of the striatum revealed dystonic attacks in tottering mice to be associated with a significant reduction in extracellular striatal dopamine. The other animal model involved the induction of dystonia via pharmacological excitation of the cerebellar cortex by local application of kainic acid in normal mice. In this model the site of stimulation determines the origin of dystonia in the cerebellum. However, subclinical striatal lesions with either 6OHDA or QA again exaggerated their generalized dystonia. When dystonic movements were triggered by pharmacological stimulation of the cerebellum, microdialysis revealed significant reductions in striatal dopamine release. These results demonstrate important functional relationships between cerebellar and basal ganglia circuits in two different animal models of dystonia. They suggest that expression of dystonic movements depends on influences from both basal ganglia and cerebellum in both models. These results support the hypothesis that dystonia may result from disruption of a motor network involving both the basal ganglia and cerebellum, rather than isolated dysfunction of only one motor system.
Article
Work over the past 2 decades has led to substantial changes in our understanding of dystonia pathophysiology. Three general abnormalities appear to underlie the pathophysiological substrate. The first is a loss of inhibition. This makes sense considering that it may be responsible for the excess of movement and for the overflow phenomena seen in dystonia. A second abnormality is sensory dysfunction which is related to the mild sensory complaints in patients with focal dystonias and may be responsible for some of the motor dysfunction. Third, evidence from animal models of dystonia as well as from patients with primary dystonia has revealed significant alterations of synaptic plasticity characterized by a disruption of homeostatic plasticity, with a prevailing facilitation of synaptic potentiation, together with the loss of synaptic inhibitory processes. We speculate that during motor learning this abnormal plasticity may lead to an abnormal sensorimotor integration, leading to consolidation of abnormal motor engrams. If so, then removing this abnormal plasticity might have little immediate effect on dystonic movements because bad motor memories have already been ''learned'' and are difficult to erase. These considerations might explain the delayed clinical effects of deep brain stimulation (DBS) in patients with generalized dystonia. Current lines of research will be discussed from a network perspective. © 2013 Movement Disorder Society.
Article
This review will consider the knowledge that neuroimaging studies have provided to the understanding of the anatomy of dystonia. Major advances have occurred in the use of neuroimaging for dystonia in the past 2 decades. At present, the most developed imaging approaches include whole-brain or region-specific studies of structural or diffusion changes, functional imaging using fMRI or positron emission tomography (PET), and metabolic imaging using fluorodeoxyglucose PET. These techniques have provided evidence that regions other than the basal ganglia are involved in dystonia. In particular, there is increasing evidence that primary dystonia can be viewed as a circuit disorder, involving the basal ganglia-thalamo-cortical and cerebello-thalamo-cortical pathways. This suggests that a better understanding of the dysfunction in each region in the network and their interactions are important topics to address. Current views of interpretation of imaging data as cause or consequence of dystonia, and the postmortem correlates of imaging data are presented. The application of imaging as a tool to monitor therapy and its use as an outcome measure will be discussed. © 2013 Movement Disorder Society.
Article
In recent years, the identification of several new dystonia genes has provided important insights into the nature of this clinically and genetically heterogeneous disorder. To identify the role of genes in the pathophysiology of dystonia. Literature review from 1985 to 2009. Early-onset dystonia is overall rare, often monogenic and tends to spread to become generalized. In contrast, adult-onset dystonia is relatively common, typically sporadic and usually remains focal. To date, 19 different forms of monogenic dystonia (primary dystonias and dystonia-plus syndromes) have been identified and classified as DYT loci. Likewise, secondary dystonia is a feature of a large number of hereditary conditions, such as Wilson disease or neuroacanthocytosis. This review focuses on the eight monogenic primary dystonias, six of which are associated with an early-onset generalized phenotype (DYT1, 2, 4, 6, 16 and 17), while the remaining two are characterized by an adolescent- or adult-onset focal or segmental form of dystonia (DYT7 and 13). Discussion: Primary dystonias have a strong genetic component that is most obvious in the rare monogenic early-onset generalized forms. However, genetic risk factors also are likely to play an important role in the pathophysiology of the much more common late-onset focal and segmental primary dystonias. The identification of these genetic factors is a critical future aim in dystonia research.
Article
Dystonia is a neurological disorder characterized by involuntary twisting movements and postures. There are many different clinical manifestations, and many different causes. The neuroanatomical substrates for dystonia are only partly understood. Although the traditional view localizes dystonia to basal ganglia circuits, there is increasing recognition that this view is inadequate for accommodating a substantial portion of available clinical and experimental evidence. A model in which several brain regions play a role in a network better accommodates the evidence. This network model accommodates neuropathological and neuroimaging evidence that dystonia may be associated with abnormalities in multiple different brain regions. It also accommodates animal studies showing that dystonic movements arise with manipulations of different brain regions. It is consistent with neurophysiological evidence suggesting defects in neural inhibitory processes, sensorimotor integration, and maladaptive plasticity. Finally, it may explain neurosurgical experience showing that targeting the basal ganglia is effective only for certain subpopulations of dystonia. Most importantly, the network model provides many new and testable hypotheses with direct relevance for new treatment strategies that go beyond the basal ganglia. This article is part of a Special Issue entitled "Advances in dystonia".
Article
Primary dystonia has traditionally been viewed as a basal ganglia disorder, but recent studies suggest that the cerebellum plays a crucial role in the disease. Primary dystonia is associated with several genotypes. Among those, DYT1 and DYT6 are inherited in autosomal dominant fashion with reduced penetrance. Extensive structural and functional imaging studies have been performed on manifesting and non-manifesting carriers of these mutations. The results suggest that primary dystonia can be viewed as a neurodevelopmental circuit disorder, involving the cortico-striato-pallido-thalamo-cortical and cerebello-thalamo-cortical pathways. Anatomical disruption of the cerebellar outflow is found in non-manifesting and manifesting mutation carriers, and a second downstream disruption in thalamo-cortical projections appears clinically protective in non-manifesting carriers. The microstructural deficits in cerebellar outflow are linked to an abnormally elevated sensorimotor network (NMRP) in dystonia patients. Abnormal expression of this network is reduced by successful treatment with deep brain stimulation. This article is part of a Special Issue entitled "Advances in dystonia".